Transscleral iontophoresis of cefazolin, ticarcillin, and gentamicin in the rabbit
- PMID: 3951811
- DOI: 10.1016/s0161-6420(86)33780-1
Transscleral iontophoresis of cefazolin, ticarcillin, and gentamicin in the rabbit
Abstract
Corneal iontophoresis produces high concentrations of drugs in the anterior segment but not in the vitreous humor of the phakic eye, presumably because transport is impeded by the lens-iris barrier. We have used two modifications to produce high levels of commonly used antibiotics in the vitreous humor of the phakic rabbit eye: the device is placed over the pars plana, circumventing the lens-iris barrier; the contact area of the column of fluid is kept small (less than or equal to 1 mm diameter) so as to provide a high current density. Applying 2 mAmp for 10 minutes, we were able to achieve mean vitreal concentrations of cefazolin, ticarcillin, and gentamicin of 94-207 micrograms/ml in the normal rabbit eye. Drug penetration showed a correlation with strength of current (0.1-2 mAmp) and with duration of iontophoresis (1-10 minutes) but not with concentration of the drug solution. Transscleral iontophoresis is a promising noninvasive technique to achieve high vitreal levels of charged solutes.
Similar articles
-
Transscleral iontophoresis of gentamicin in monkeys.Invest Ophthalmol Vis Sci. 1987 Jun;28(6):1033-6. Invest Ophthalmol Vis Sci. 1987. PMID: 3583629
-
Regional ocular gentamicin levels after transcorneal and transscleral iontophoresis.Invest Ophthalmol Vis Sci. 1990 May;31(5):909-16. Invest Ophthalmol Vis Sci. 1990. PMID: 2335452
-
An improved apparatus for transscleral iontophoresis of gentamicin.Invest Ophthalmol Vis Sci. 1992 Dec;33(13):3543-5. Invest Ophthalmol Vis Sci. 1992. PMID: 1464499
-
Basic principles and current status of transcorneal and transscleral iontophoresis.Expert Opin Drug Deliv. 2017 Sep;14(9):1091-1102. doi: 10.1080/17425247.2017.1266334. Epub 2016 Dec 11. Expert Opin Drug Deliv. 2017. PMID: 27892757 Review.
-
Device drug delivery to the eye. Collagen shields, iontophoresis, and pumps.Ophthalmology. 1991 May;98(5):725-32. doi: 10.1016/s0161-6420(91)32227-9. Ophthalmology. 1991. PMID: 2062508 Review.
Cited by
-
A histopathologic study of retinal lesions inflicted by transscleral iontophoresis.Graefes Arch Clin Exp Ophthalmol. 1991;229(4):389-94. doi: 10.1007/BF00170699. Graefes Arch Clin Exp Ophthalmol. 1991. PMID: 1916328
-
Antibiotic therapy for ocular infection.West J Med. 1994 Dec;161(6):579-84. West J Med. 1994. PMID: 7856158 Free PMC article. Review.
-
Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging.Int J Pharm. 2007 Apr 20;335(1-2):46-53. doi: 10.1016/j.ijpharm.2006.11.001. Epub 2006 Nov 3. Int J Pharm. 2007. PMID: 17236728 Free PMC article.
-
Recent perspectives in ocular drug delivery.Pharm Res. 2009 May;26(5):1197-216. doi: 10.1007/s11095-008-9694-0. Epub 2008 Aug 29. Pharm Res. 2009. PMID: 18758924 Free PMC article. Review.
-
Application of Hydrogels in the Device of Ophthalmic Iontophoresis: Theory, Developments and Perspectives.Gels. 2023 Jun 26;9(7):519. doi: 10.3390/gels9070519. Gels. 2023. PMID: 37504398 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous